Granulytics is a pioneering biotech spinoff born from collaborative efforts between academic researchers, focused on combating antimicrobial resistance (AMR) through innovative biological therapies. Leveraging antimicrobial proteins and lipid nanocarriers, Granulytics aims to address the urgent need for effective treatments against bacterial infections, particularly in settings vulnerable to AMR.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Section Médecine, Anatomie, Rte A. Gockel 1, Fribourg,fribourg 1700,switzerland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Héphaïstos.
- HQ
- Fribourg, Fribourg
Granulytics Questions
Granulytics's LinkedIn profile is https://ch.linkedin.com/company/granulytics
Granulytics has
2 employees.
View email and phone details for 2
employees at Granulytics.
Granulytics's industry is
Biotechnology Research
Granulytics's top competitors are
Red Drop Lab.,
Héphaïstos,
Transeasy Medical Tech. Co., Ltd.,
Cadd Consulting Gmbh,
Diffraqtion,
Technit Gmbh,
Vikyng,
Mobipolter,
Apricot Bio,
Leafsheep.
Granulytics's categories are Biotechnology Research
Granulytics's founding year is 2023
